Status:
COMPLETED
Anesthesia for Vascular Access Devices
Lead Sponsor:
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
Collaborating Sponsors:
Trakya University Faculty of Medicine
Conditions:
Opioid Use, Unspecified
Remifentanil
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
Our aim was to investigate whether remifentanil use in both infusion and bolus techniques could provide sufficient sedation and analgesia without serious adverse effects for central venous access devi...
Detailed Description
The insertion and removal of implantable venous access devices (port-a-cath type) requires moderate level of sedation and monitored anesthesia care to prevent pain and anxiety of patients during the p...
Eligibility Criteria
Inclusion
- 30-80 years old,
- American Society of Anesthesiologists Physical Status I to III,
- Referred for an venous access device implantation or removal procedure.
Exclusion
- morbid obesity (body mass index \> 40),
- severe asthma, chronic obstructive lung disease, diabetes mellitus, hepatorenal disease,
- a history of opioid allergy,
- long-term opioid use or chronic pain,
- ASA PS ≥ 4,
- presence of epilepsy,
- acute cerebrovascular event,
- presence of hemodynamical instability such as peripheral oxygen saturation \< 90%, systolic blood pressure \< 60 mmHg and heart rate ≤ 40 bpm,
- patients complaining about intense pain before the procedure.
Key Trial Info
Start Date :
August 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT04749069
Start Date
August 1 2012
End Date
June 30 2020
Last Update
February 10 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Trakya University Faculty of Medicine Department of Anesthesiology
Edirne, Turkey (Türkiye), 22030
2
Kartal Kosuyolu High Speciality Training and Research Hospital
Istanbul, Turkey (Türkiye), 34846